Kinnate Biopharma (KNTE): Price and Financial Metrics
KNTE Price/Volume Stats
| Current price | $2.65 | 52-week high | $7.18 |
| Prev. close | $2.66 | 52-week low | $1.04 |
| Day low | $2.64 | Volume | 2,812,200 |
| Day high | $2.68 | Avg. volume | 418,678 |
| 50-day MA | $2.48 | Dividend yield | N/A |
| 200-day MA | $2.27 | Market Cap | 125.15M |
KNTE Stock Price Chart Interactive Chart >
Kinnate Biopharma (KNTE) Company Bio
Kinnate Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA.
KNTE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 8.16% |
| 3-year | -83.94% |
| 5-year | N/A |
| YTD | 11.81% |
| 2023 | -61.15% |
| 2022 | -65.58% |
| 2021 | -55.46% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...